Novel use of psychedelics for heart disease and mental health: treatment and ethics
Journal of Prescribing Practice October 2, 2021 Peer reviewed DOI: 10.12968/jprp.2021.3.10.388 via Semantic Scholar
Abstract
No abstract available from the source.
Related reading
- Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
- Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol. Open Science Framework • July 9, 2026 • via OpenAlex
- Sex-specific outcomes of developmental stress and psilocybin intervention on the brain and behavior Universitätsbibliothek der LMU • July 9, 2026 • via OpenAlex
- Treating addiction with an addictive drug: the ketamine paradox revisited Frontiers in Psychiatry • July 9, 2026 • via OpenAlex
- Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression Journal of Psychopharmacology • July 8, 2026 • via OpenAlex